• info@hekamedicals.com
  • +91 97 7841 0630
Heka Medicals India Pvt Ltd
  • Home
  • Features
  • Certifications
  • Testimonials
  • More
    • Our Clients
    • About Us
    • Webstore
    • Contact
    • Resources
    • Gallery

HekaFlo HM-P-5OO,  HFNC device developed by Heka Medicals India Pvt Ltd, has been tested for clinical performance at our institution. The device was used in our Intensive care unit in hypoxemic patients with post COVID pneumonia and patients weaned from ventilator. The clinical performance of the device was found to be satisfactory during the trial period. We also observed that HekaFlo HFNC is quite and user- friendly with many innovative features.

Dr. Suresh G. Nair, MD, FIACTA, FTEE

Senior Consultant Anesthesiology and Critical Care Medicine, Aster Medcity, Kochi.

HekaFlo HFNC device manufactured by Heka Medicals India Pvt Ltd is being used in our ICU for COVID-19 as well as post COVID pneumonia/fibrosis patients for the last six months. During this period regarding the clinical efficacy and utility, the following observations were made.

  • Its clinical performance is in par with the other standard HFNC machines available in the medical industry.
  • Its interface is very user-friendly, accurate and has many advanced features like inbuilt O2 flow meter calculator, ROX index calculator, SPO2 monitoring and IoT enabled remote monitoring features which are not available in any other standard HFNC machines.
  • The clinician can also retrieve the patient’s oxygen requirements and other vital statistics at a later point of time, which is very useful for clinical analysis and research.
  • In fact, in one of our patients with post COVID lung fibrosis the HekaFlo HFNC machine was used almost continuously for about a month and the patient was successfully weaned off from respiratory support.
  • The support services from the Heka team were prompt and comprehensive.
  • ICU staff nurses/respiratory therapists commented that it was easy for them to understand the basic technical aspects, alarm settings of the machine and change.

Dr. Mathew Pulicken MD, IDCCM, EDICU

Associate Professor & HOD, Critical Care Medicine, Pushpagiri Medical College Hospital, Thiruvalla.

HekaFlo HFNC machine was demonstrated and used in the Coronary Care Unit of Lisie Heart Institute for hypoxemic patients with heart failure.

Name & Model of the Machine : HekaFlo HM-P-500
Name of the manufacturer : Heka Medicals India Pvt. Ltd.

I am satisfied with the performance of the machine and is in par with the other HFNC machines used in our department. The machine is very user friendly and has many innovative features like remote monitoring which makes it very useful not only in CCU setups but also in patients in HOU & rooms.
Dr Rony Mathew Kadavil MD, DNB (Medicine), DM, DNB (Cardiology) FCSI, FSCAI, FACC, FESC, FRCP
Head of Department – Cardiology, Lisie Hospital, Kochi.

Heka Flo HM-P-500 HFNC device developed by Heka Medicals India Pvt ltd, has been evaluated for clinical performance at our institution. The device was used in our 23 bedded Paediatric Intensive Care Unit. The performance of the device was found satisfactory, during the trial period. We also observed that Heka Flo HFNC is very user friendly and has many innovative features like wi-fi enabled remote monitoring, flow meter button, RoX Index Calculation which makes this device highly useful among different clinical services. HekaFlo HM-P-500 HFNC device meets all the technical specifications and features as mentioned in the brochure.

Dr. Kala Ebenezer MD.DCH

Prof & Head, Paediatric Intensive Care Unit, Christian Medical College, Vellore.

HekaFlo HM-P-500, loT enabled High flow nasal oxygenation Therapy (HFNC/HFNO) device developed by Heka Medical India Pvt Ltd, had been tested for clinical Performance at our  institution.  The device was used  in  our intensive care unit  in hypoxemic  patients  with  Covid  and  Post  Covid  pneumonia ·The clinical performance of the device was found to be satisfactory during the trial period. We also observed that HekaFlo HFNC is quite user- friendly with many innovative features.

Dr. Indhu Rajeev MBBS DNB FICM

Consultant Critical Care, Lourdes Hospital, Kochi.

High Flow Nasal Oxygen therapy device (HekaFlo HM-P-500) developed by Heka Medicals India Pvt. Ltd has been tested for clinical demonstration in the Intensive Care Unit at Pushpagiri Institute of Medical Sciences, Thiruvalla, Kerala from 22/07/2021 to 09/08/2021. During the trial period, we have observed that the device is very user friendly, has many advanced features, meets all the technical specifications, and has overall satisfactory performance. We used the device for delivering High flow oxygen therapy in patients with hypoxemic respiratory failure secondary to COVID Phenomenon / Post-Covid lung fibrosis. Patient compliance with the device was also found to be good.

Dr. Sethu Babu MD,DTCD,FICM
Dept of Emergency Medicine and critical care, Pushpagiri Institute of Medical sciences, Thiruvalla.

HekaFlo HM-P-500 is a respiratory support system for the treatment of spontaneously breathing hypoxic patients with humidified and heated oxygen at a flow rate of up to 60 LPM

DETAILS

Features

Certifications

Testimonials

Webstore

Our Clients

CONTACT
Heka Medicals India Pvt Ltd
KRIBS-BIONEST
Kerala Technology Innovation Zone
KINFRA Hi Tech Park
Kalamassery, Kochi - 683503
Ph : +91 97 7841 0630
Email : info@hekamedicals.com
KNOW MORE

About Us

Contact Us

Resources

Gallery

Privacy Policy

Cookie Policy

© 2022 Heka Medicals India Pvt Ltd. All Rights Reserved.